Correction to: British Journal of Cancer (2011) 106, 133–140. doi:10.1038/bjc.2011.504
Upon publication of this paper earlier in Volume 106, the authors noticed an error in Figure 2, whereby panels A and B were exact duplicates. The correct Figure is now shown below.
Analysis of distant metastasis-free survival and cause-specific survival. (A) Patients classified in the high-risk group (based on CDK1SA >11 maU eU–1) had a significantly worse distant metastasis event rate as compared with the low-risk group (HR=6.2, 95% CI: 1.45–26.9, P=0.0049; exact conditional Monte-Carlo P-value=0.029). (B) Patients classified in the CDK1SA-based high-risk group had a significantly lower cause-specific survival (HR=7.62, 95% CI: 1.80–32.2, P=0.001).
The authors would like to apologise for this error.
Change history
29 March 2012
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
Additional information
The online version of the original article can be found at 10.1038/bjc.2011.504
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Zeestraten, E., Maak, M., Shibayama, M. et al. Erratum: Specific activity of cyclin-dependent kinase I is a new potential predictor of tumour recurrence in stage II colon cancer. Br J Cancer 106, 792 (2012). https://doi.org/10.1038/bjc.2012.38
Published:
Issue Date:
DOI: https://doi.org/10.1038/bjc.2012.38
